Literature DB >> 28826158

The cardiac surgery-associated neutrophil gelatinase-associated lipocalin score for postoperative acute kidney injury: Does subclinical acute kidney injury matter?

Hilde R de Geus1, Michael Haase2, Laurent Jacob3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28826158     DOI： 10.1016/j.jtcvs.2017.05.005

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  4 in total

1.  Urinary KIM-1 Correlates with the Subclinical Sequelae of Tubular Damage Persisting after the Apparent Functional Recovery from Intrinsic Acute Kidney Injury.

Authors:  Cristina Cuesta; Isabel Fuentes-Calvo; Sandra M Sancho-Martinez; Floris A Valentijn; Annette Düwel; Omar A Hidalgo-Thomas; Consuelo Agüeros-Blanco; Adalberto Benito-Hernández; María A Ramos-Barron; Carlos Gómez-Alamillo; Manuel Arias; Tri Q Nguyen; Roel Goldschmeding; Carlos Martínez-Salgado; Francisco J López-Hernández
Journal:  Biomedicines       Date:  2022-05-10

2.  Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.

Authors:  Rajaa Marouf; Adekunle D Adekile; Hadeel El-Muzaini; Rasha Abdulla; Olusegun A Mojiminiyi
Journal:  Ann Hematol       Date:  2021-04-02       Impact factor: 3.673

3.  Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury.

Authors:  Víctor Blanco-Gozalo; Alfredo G Casanova; Sandra M Sancho-Martínez; Marta Prieto; Yaremi Quiros; Ana I Morales; Carlos Martínez-Salgado; Consuelo Agüeros-Blanco; Adalberto Benito-Hernández; María A Ramos-Barron; Carlos Gómez-Alamillo; Manuel Arias; Francisco J López-Hernández
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

4.  Urine neutrophil gelatinase-associated lipocalin and urine output as predictors of the successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury.

Authors:  Josefine Thomsen; Ulrik Sprogøe; Palle Toft
Journal:  BMC Nephrol       Date:  2020-08-28       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.